PGHLUpdated 2 Sept 2026, 0:32

Procter & Gamble Health L

PGHLUpdated 2 Sept 2026, 0:32

Market Cap

₹9,600Cr.

Current Price

₹5,776

High / Low

₹6,975/4,700

Stock P/E

28.8

ROE61.9%

ROCE83.9%

Book Value₹316

Face Value₹10.0

Dividend Yield2.68%

About

P&G Health Ltd (formerly Procter & Gamble td) (erstwhile Merck Limited) is engaged in the business of manufacturing and marketing of pharmaceuticals and chemicals.[1]

Quarterly results

Last reported quarters₹ Cr.

Profit & loss

Annual statement₹ Cr.

Shareholding pattern

As of Jun 2026%

Shareholding trend

Ownership over time%

Balance sheet

Assets & liabilities₹ Cr.

Cash flows

Operating, investing & financing₹ Cr.

Key ratios

Historical financial ratios

Category	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Jun 2020	Jun 2021	Jun 2022	Jun 2023	Jun 2024	Mar 2025	Mar 2026
Debtor Days	49	39	64	28	30	26	22	27	34	27	57	43
Inventory Days	140	145	243	154	139	113	138	124	136	120	152	137
Days Payable	55	67	128	124	106	105	209	185	239	184	239	192
Cash Conversion Cycle	134	118	179	58	63	34	-49	-34	-69	-37	-30	-13
Working Capital Days	69	52	94	42	22	23	7	17	15	19	48	30
ROCE %	15%	18%	16%	78%	20%	29%	29%	38%	45%	45%	48%	84%

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 2 September 2026 at 0:32

PROCTER & GAMBLE HEALTH L (PGHL) financials — quarterly results, P&L, cash flow, balance sheet, shareholding